Pamela Morris to Cardiology
This is a "connection" page, showing publications Pamela Morris has written about Cardiology.
Connection Strength
3.874
-
2019 Methodology for Heart House Roundtables: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019 08 27; 74(8):1116-1137.
Score: 0.595
-
2019 Methodology for Creating Expert Consensus Decision Pathways: A Report of the American College of Cardiology. J Am Coll Cardiol. 2019 08 27; 74(8):1138-1150.
Score: 0.595
-
Highlights of the American College of Cardiology Annual Scientific Sessions 2019. Circulation. 2019 06 11; 139(24):2793-2795.
Score: 0.590
-
Consensus between the American College of Cardiology and the National Lipid Association on the use of non-statin therapy for atherosclerotic cardiovascular disease prevention. J Clin Lipidol. 2016 May-Jun; 10(3):458-61.
Score: 0.475
-
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022 10 04; 80(14):1366-1418.
Score: 0.184
-
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 08 31; 78(9):960-993.
Score: 0.171
-
ACC.21 Virtual: Experience an Opportunity to Reconnect and Engage. J Am Coll Cardiol. 2021 04 20; 77(15):1949-1951.
Score: 0.168
-
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 09 01; 76(9):1117-1145.
Score: 0.160
-
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. J Am Coll Cardiol. 2019 10 15; 74(15):1926-1942.
Score: 0.151
-
Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018?AHA/ACC Cholesterol Guidelines. J Am Coll Cardiol. 2019 08 06; 74(5):712-714.
Score: 0.149
-
2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018 12 25; 72(25):3332-3365.
Score: 0.142
-
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry. Circ Cardiovasc Qual Outcomes. 2018 05; 11(5):e004652.
Score: 0.137
-
2017 Focused Update of the 2016?ACC?Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in?the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2017 Oct 03; 70(14):1785-1822.
Score: 0.131
-
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2016 07 05; 68(1):92-125.
Score: 0.118
-
What the guidelines do not say: statin non-benefit groups. Curr Atheroscler Rep. 2015 Jan; 17(1):468.
Score: 0.108